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Summary
Background: Mycobacterium avium complex (MAC) often causes disseminated infection in
patients at an advanced stage of HIV infection; however, peritonitis associated with disseminated
MAC infection is rare.
Methods: In this report, we describe five cases of MAC peritonitis in AIDS patients at our hospital,
and analyze these cases alongside 11 previously published cases found in the literature.
Results: Most of the AIDS patients with MAC peritonitis had CD4 counts of <50 cells/ml and
elevated alkaline phosphatase levels. Other than ascites, MAC was also isolated from other sterile
and non-sterile sites. Of note, six patients (37.5%) presented with chylous ascites.
Conclusions: Despite therapy, MAC peritonitis is associated with a grave outcome.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Mycobacterium avium complex (MAC) infection is a common
complication of advanced-stage HIV-1 infection, which often
occurs in patients with CD4 lymphocyte counts of <50 cells/
ml.1 Before the introduction of highly active antiretroviral
therapy (HAART) and primary prophylaxis, MAC infection in
those patients at an advanced stage of HIV infection was* Corresponding author. Tel.: +886 2 23123456x7552;
fax: +886 2 23707772.
E-mail address: hcc0401@ntu.edu.tw (C.-C. Hung).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.07.016often associated with significant mortality and morbidity.
Although the incidence of MAC infection has declined sub-
stantially in the era of HAART, it continues to occur in
patients without access to HAARTor in patients who develop
virological and immunological failure to HAART due to drug
intolerance or the emergence of antiretroviral resistance.2
MAC can be isolated from non-sterile sites, such as speci-
mens of the gastrointestinal and respiratory tracts, which
may represent colonization or disseminated infection. In
disseminated MAC infection, the organs most commonly
involved are the spleen, lymph nodes, liver, intestines,
and bone marrow; the lungs, adrenals, stomach, and centralPublished by Elsevier Ltd. All rights reserved.
Figure 1 Computed tomography of the abdomen after admin-
istration of contrast medium showing thickened bowel wall and
mesentery in an AIDS patient with Mycobacterium avium com-
plex peritonitis.
286 U.-I. Wu et al.nervous system are less commonly involved.3 Although MAC is
a well-described pathogen in AIDS patients, peritonitis due to
MAC has rarely been described.4 In this report we describe
five cases of peritonitis due to MAC and review the literature.
Methods
Between June 1994 and February 2008, 1778 non-hemophi-
liac HIV-infected adult patients who sought medical care at
the National Taiwan University, the largest referral hospital
for HIV inpatient and outpatient care in Taiwan, were con-
secutively enrolled in an observational study to describe the
clinical spectrum of HIV-related opportunistic illnesses. Over
the 14-year study period, 88 patients (4.9%) were diagnosed
as having MAC infection; among these patients, 46 (52.3%)
had disseminated MAC infection that was diagnosed based on
the isolation of MAC from sterile sites. Five patients had MAC
isolated from ascites and presented with clinical manifesta-
tions consistent with peritonitis. A standardized case record
form was used to collect clinical information on these five
patients.
We also reviewed the literature available on this subject
by performing a PubMed search using the terms ‘Mycobac-
terium avium complex and peritonitis’, ‘AIDS and peritoni-
tis’, ‘HIV and peritonitis’, ‘Mycobacterium avium complex
and ascites’, and ‘Mycobacterium avium and ascites’. The
abstracts of the articles selected in each of these multiple
searches were identified, and those dealing particularly with
the subject were recorded and reviewed in full form. Clinical
presentations, relevant laboratory results, treatment
course, and overall outcome were recorded.
The diagnosis of MAC peritonitis required the isolation of
the organisms from ascites fluid either by culture or mole-
cular biology assays. Disseminated MAC infection was defined
as isolation of MAC from the blood, bone marrow, liver biopsy
specimen, or specimens from two or more non-contiguous
sites. Patients with MAC isolates recovered from specimens of
respiratory tract (sputum, bronchoalveolar lavage, or sinus
aspirate), gastrointestinal tract (gastric lavage, colon biopsy,
or stool sample), or wound were not considered to have
disseminated MAC infection when cultures of sterile sites
were negative. Chylous ascites was defined as a milky-
appearing peritoneal fluid that was rich in triglyceride
(200 mg/dl).
Results
Case report
A 42-year-old homosexual man with a CD4 count of 13 cells/
ml, who had failed to respond to HAART, sought medical care
at an outside hospital because of intermittent high fever,
diffuse abdominal pain, watery diarrhea, and weight loss for
6 months. He had no history of liver disease or alcohol abuse.
A diagnosis of sclerosing mesenteritis was presumptively
made according to the findings of computed tomography
(CT) of the abdomen. He later presented to our hospital with
aggravation of the above symptoms after several months of
conservative treatment.
On physical examination, the patient’s temperature was
38 8C. He was cachectic, with temporal wasting. His abdomenwas markedly distended with a doughy consistency on palpa-
tion and dullness on percussion. There was diffuse abdominal
tenderness with mild muscle guarding and rebound tender-
ness. The liver and spleen could not be palpated.
Initial laboratory data included: white blood cell count
(WBC) of 3.73  109 cells/l with 85.2% neutrophils, 7.8%
lymphocytes, 6.7% monocytes, and 0.3% basophils, hemoglo-
bin 12.2 g/dl, platelets 194  109 cells/l, aspartate amino-
transferase 50 U/l, alanine aminotransferase 21 U/l, alkaline
phosphatase (ALP) 125 U/l, and C-reactive protein 11.5 mg/
dl. CT of the abdomen showed dirty fat stranding with
increased density of the central mesentery with enlarged
lymph nodes and wall thickening of the small bowel
(Figure 1). Diagnostic laparoscopy revealed severe adhesion
of the omentum to the small intestine and massive turbid
ascites. Further analysis yielded lymphocytic ascites with a
WBC count of 0.7  109/l, glucose 118 mg/dl, lactate dehy-
drogenase 787 U/l, and a serum-to-ascites albumin gradient
(SAAG) of 1.6 g/dl. Acid-fast stain of the omentum specimen
was strongly positive for mycobacteria, while that of the
ascites specimen was negative. Anti-tuberculous therapy
with rifabutin, isoniazid, ethambutol, and pyrazinamide
were initiated along with antiretroviral therapy. Cultures
of the patient’s sputum, ascites, and omentum tissue subse-
quently yielded MAC. Although mild alleviation of abdominal
symptoms was soon observed after his regimen was changed
to clarithromycin, ethambutol, amikacin, and levofloxacin,
relapse occurred several weeks later because of intolerance
to the antiretroviral therapy.
Literature review
A total of five published reports of 11 cases of MAC peritonitis
were identified in the literature,5—9 and alongside the five
cases diagnosed at this hospital, 16 cases of MAC peritonitis in
patients with HIV infection were reviewed. Table 1 sum-
marizes the clinical presentations of these 16 patients.
The majority were male, and the median age was 36 years
(range 23—50 years). Liver cirrhosis was documented in two
of them. Most of the patients had CD4 counts below 50 cells/
Table 1 Clinical characteristics of 16 HIV-infected patients with Mycobacterium avium complex peritonitis.
Ref. Age/
sex
CD4 (/ml) PVL
(copies/ml)
ART Fever Other
symptoms
ALP (U/l) Other sites of
MAC infection
Character
(TG)
SAAG
(g/dl)
TP
(g/dl)
PMN
(cells/mm3)
Anti-MAC
therapy
Outcome
5 NA <50 NA NA NA No 172 NA NA 1.1 1.3 350 NA NA
5 NA <50 NA NA NA No 118 NA NA 1.6 0.8 2 NA NA
5 NA <50 NA NA NA No 547 Liver NA 1.3 1.3 3 NA NA
5 NA Mean 17
(for 4 cases)
NA NA NA NA 2265 Blood NA NA 2.8 18 3 agents NA
5 NA NA NA NA NA 889 Blood NA 1.0 NA 70 3 agents NA
5 NA NA NA NA NA 447 Blood NA NA 2.8 474 3 agents NA
5 NA NA NA NA NA 2190 Blood NA NA NA NA 3 agents NA
6 42/M 0 NA Yes Yes Weight loss,
abdominal
distension,
lower
leg swelling
NA Blood, stool Milky NA 3 WBC 90,
lymphocytes
predominant
Ciprofloxacin,
clofazimine,
ethambutol,
rifabutin
Died
7 47/M 81 <50 Yes No Testicular
swelling,
abdominal
distension
67 Blood, bone
marrow,
sputum,
peritoneum,
mesentery
Cloudy,
yellow— green
0.8 5.1 WBC 432,
L:N:M:H
44:22:30:4
Clarithromycin,
ethambutol,
ciprofloxacin,
rifabutin,
amikacin
Improved
8 35/M 20 NA NA Yes Weight loss,
abdominal
pain, night
sweat
333 Blood, sputum Milky NA 11.7 WBC 31 Clarithromycin,
ethambutol,
ciprofloxacin,
rifabutin,
amikacin
Improved
9 29/M NA NA NA NA Abdominal
pain
NA Supra-
clavicular LN
Milky NA NA NA NA Died
PR 42/M 13 572 800 Poor
compliance
Yes Abdominal
pain,
diarrhea
125 Sputum,
omentum
Yellowish,
turbid
1.6 Alb: 2.07 WBC 700,
L:N:M&H
41:19:40
Clarithromycin,
ethambutol,
levofloxacin,
amikacin
Relapse
PR 50/M 28 <50 Yes No Abdominal
pain,
diarrhea
274 Sputum,
blood
Milky 1.9 Alb: 0.18 WBC 300,
L:N:M&H
2:97:1
Clarithromycin,
ethambutol,
levofloxacin,
amikacin
Died
PR 23/M 2 39 800 Poor
compliance
Yes Abdominal
pain,
diarrhea,
weight loss
257 Sputum,
intra-
abdominal LN
Milky NA NA NA Clarithromycin,
ethambutol,
ciprofloxacin,
rifampin
Improved
M
A
C
p
e
rito
n
itis
an
d
A
ID
S
287
Figure 2 Computed tomography of the abdomen after admin-
istration of contrast medium in another AIDS patient with MAC
peritonitis showing enlarged para-aortic and mesenteric lymph
nodes.
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288 U.-I. Wu et al.ml, whereas their plasma HIV RNA loads ranged from an
undetectable level to greater than 750 000 copies/ml. Seven
of the patients were reported to have received antiretroviral
therapy when MAC peritonitis developed. While abdominal
pain and distension were common presenting symptoms, not
all patients reported fever. Body weight loss and diarrhea
were also frequently documented.
All of the patients had ascites cultures that were positive
for MAC except one patient whose diagnosis was made by
molecular methods. In addition to ascites specimens, most of
them had MAC isolated from other sterile and non-sterile
sites (Table 1). Blood cultures were performed in eleven
patients, which identified nine patients (81.8%) with myco-
bacteremia. Three patients had bone marrow involvement
that was detected by biopsy and cultures (Table 1). The WBC
count was usually normal without leukopenia. Aminotrans-
ferase levels weremostly normal or slightly elevated. Eight of
the thirteen patients (61.5%) had ALP levels greater than 300
U/l (median 390, range 67—2265); liver involvement was
documented in two of these patients by liver biopsy. Portal
hypertension was present in most of the patients (62.5%) with
SAAG >1.1 (Table 1). The cells of the ascites were predomi-
nantly lymphocytes. Ascites from seven patients (43.8%)
were described asmilky, and chylous ascites was documented
in six patients (37.5%). Nearly all of the abdominal imaging
studies were characterized by thickened mesentery together
with multiple, enlarged lymph nodes in the mesentery roots
(Figure 2).
Most of the patients were treated with three to five
combined anti-MAC agents (Table 1). Clinical and microbio-
logic improvement was observed in only three patients. Two
patients died 3 months after MAC peritonitis was diagnosed
despite therapy with four anti-MAC agents. The remaining
patients did not respond to anti-MAC therapy or subsequently
developed relapse and died.
Discussion
While peritonitis is an uncommon finding in AIDS patients,10
MAC was the most common organism isolated from ascites
according to a previous study of 54 HIV-infected patients;5
MAC peritonitis and AIDS 289yet little is known about the clinical features of MAC peri-
tonitis since only discrete case reports are available in the
literature. In this report, we have identified 16 cases of AIDS-
associated MAC peritonitis for analysis of their clinical pre-
sentations. Other than peritonitis, almost all of the patients
presented with disseminated MAC infection, with MAC iso-
lated from other sterile sites at the time of diagnosis. Some
patients had already been diagnosed as having MAC infection
at other body sites a few months or years earlier. Peritonitis
appeared to be a late presentation of disseminated MAC
infection. Previous anti-MAC therapy did not prevent further
MAC dissemination because of non-compliance with anti-MAC
medications and virological and immunological failure to
antiretroviral therapy.
Traditional criteria for the diagnosis of peritonitis are
useful for bacterial causes, but may be less helpful in peri-
tonitis due to MAC infection. Nine patients in our series had
absolute neutrophil counts in the ascites specimens of
<0.25  109 cells/l.11 The diagnosis of infected ascites
may consequently be delayed, especially when acid-fast
smears are negative. The findings of a high WBC count and
a high SAAG (>1.1 g/dl) and total protein levels (predomi-
nantly 2.5 g/dl) of the ascites specimens may make it
difficult to differentiate these cases from secondary bacter-
ial peritonitis.12 Therefore, routine cultures of the ascites for
bacteria, fungi, and mycobacteria are important to make an
etiological diagnosis of peritonitis. However, before culture
results are available, differentiation between tuberculous
and MAC peritonitis still poses a significant challenge in HIV-
infected patients with ascites that are smear-positive for
acid-fast bacilli, because clinical manifestations of the two
diseases are similar, and it may take weeks for routine
mycobacterial culture results to become available. With
the recent introduction of molecular diagnostic modalities,
the time required to make an etiological diagnosis can be
shortened and target therapy can be administered earlier
than in cases where the diagnosis is made based on routine
microbiological identification.
Chylous ascites is an uncommon finding with a reported
incidence of approximately 1 per 20 000 admissions at a
large university-based hospital over a two-decade period.13
In developed countries, it is most frequently associated
with malignancy and has a poor prognosis.13 A previous
review of the literature identified nine cases of AIDS
patients with chylous ascites.14 Mycobacterium tuberculo-
sis, MAC, and Kaposi’s sarcoma have been reported to be
associated with chylous ascites in these patients. Summing
up the results from previous reports and our present study,
we found that MAC was responsible for the cause of chylous
ascites in half of the AIDS patients. As demonstrated in our
review, nearly all of the abdominal image studies of MAC
peritonitis revealed thickened mesentery with multiple,
enlarged lymph nodes in their mesentery roots, and the
pathogenesis of chylous ascites may be related to the
involvement of retroperitoneal lymph nodes or lymphatic
drainage by MAC.
Management of MAC peritonitis in HIV-infected patients
may be difficult in view of chylous ascites and severe immu-
nosuppression in the face of virological and immunological
failure to HAART. Our review suggests that MAC peritonitis,
similar to what was observed in HIV-infected patients with
disseminated MAC infection in the pre-HAART era,15 is asso-ciated with a poor outcome despite anti-MAC therapy if
immune restoration cannot be achieved.
The increased likelihood of developing immune reconstitu-
tion inflammatory syndrome (IRIS) in HIV-infected patients
after HAART adds to the difficulties in management of MAC
infectionand theevaluationof treatment response.Asmanyas
31.4% of patients with MAC infection develop IRIS after initia-
tion of HAART.16 In these patients, one of the most frequent
manifestations of IRIS is worsening of localized lymphadenitis.
In a recently published retrospective study of MAC-associated
IRIS, patients with abdominal adenopathy responded less well
to IRIS treatment than those with peripheral adenopathy.17
This may partially explain the delay in resolution of chylous
ascites in some of the patients, despite antimicrobial therapy
and a good virological response to HAART.
In conclusion, we have reviewed 16 cases of MAC perito-
nitis in patients at an advanced stage of HIV infection. A
clinical diagnosis can rarely be made based on clinical pre-
sentation alone, given the presence of non-specific symptoms
and signs in patients with disseminated MAC infection. MAC
peritonitis as part of disseminated MAC infection is asso-
ciated with a grave outcome despite treatment with combi-
nations of anti-MAC agents.
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